Institut für Klinische Chemie und Laboratoriumsmedizin
Klinikum / Johannes Gutenberg-Universität Mainz
Schnabel, R; Messow, CM; Lubos, E et al.
Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene studyEur Heart J. Bd. 29. H. 5. 2008 S. 649-657
Brückner, M; Peetz, D; Lasarzik, I et al.
Charakterisierung der Plasmakonzentration von rekombinantem humanen aktivierten Protein C nach Bolusgabe und Infusion bei der RatteAnästhesologie und Intensivmedizin Abstract CD. 2008 S. PO 3.2.4
Seiler, S; Schlitt, A; Jiang, XC et al.
Cholesteryl ester transfer protein activity and cardiovascular events in patients with chronic kidney disease stage VNephrol Dial Transplant. Bd. 23. H. 11. 2008 S. 3599-3604
Maegdefessel, L; Buerke, M; Schubert, S et al.
Comparison of bivalirudin, enoxaparin, and unfractionated heparin in preventing cardiac catheter thrombosisThromb Haemost. Bd. 100. H. 4. 2008 S. 693-698
Espinola-Klein, C; Rupprecht, HJ; Bickel, C et al.
Different calculations of ankle-brachial index and their impact on cardiovascular risk prediction.Circulation. Bd. 118. H. 9. 2008 S. 961-967
Lehmann, HW; Plentz, A; von Landenberg, P et al.
Different patterns of disease manifestations of parvovirus B19-associated reactive juvenile arthritis and the induction of antiphospholipid-antibodiesClin Rheumatol. Bd. 27. H. 3. 2008 S. 333-338
Brückner, M; Lasarzik, I; Peetz, D et al.
Effects of activated protein C on histopathological damage, cerebral bloodflow and neurological outcome after forebrain ischemia in ratsJ Neurosurg Anesth. Bd. 20. H. 4. 2008 S. 323
Brückner, M; Lasarzik, I; Peetz, D et al.
Effects of activated protein C on neuronal injury after cerebral ischemia in ratsAnesthesiology. Bd. 109. H. Supp. 2008 S. A77
Drechsler, MD; Obermeier, I; Döring, Y et al.
Generation of multifunctional murine monoclonal antibodies specifically directed to the VP1unique region protein of human parvovirus B19.Immunobiology. Bd. 213. 2008 S. 511-517
Espinola-Klein, C; Rupprecht, HJ; Bickel, C et al.
Impact of inflammatory markers on cardiovascular mortality in patients with metabolic syndrome.Eur J Cardiovasc Prev Rehabil. Bd. 15. H. 3. 2008 S. 278-84
Schlitt, A; Rupprecht, HJ; Reindl, I et al.
In-vitro comparison of fondaparinux, unfractionated heparin, and enoxaparin in preventing cardiac catheter-associated thrombusCoron Artery Dis. Bd. 19. H. 4. 2008 S. 279-284
Tanne, D; Katzav, A; Beilin, O et al.
Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndromeNeurobiol Dis. Bd. 30. H. 1. 2008 S. 56-64
Papaspyrou, K; Rossmann, H; Fottner, C et al.
Malignant paraganglioma caused by a novel germline mutation of the succinate dehydrogenase D-gen e- a case reportHead Neck J Scispec. Bd. 30. H. 7. 2008 S. 964-969
Torzewski, M; Reifenberg, K; Cheng, F et al.
No effect of C-reactive protein on early atherosclerosis in LDLR-/ C-reactive protein transgenic mice.Thromb Haemost. Bd. 99. H. 1. 2008 S. 196-201
Morange, PE; Tregouet, DA; Godefroy, T et al.
Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study.J Mol Med. Bd. 86. H. 10. 2008 S. 1153-1161
Schwarz, M; Spath, L; Lux, CA et al.
Potential protective role of apoprotein J (clusterin) in atherogenesis: binding to enzymatically modified low-density lipoprotein reduces fatty acid-mediated cytotoxicityThromb Haemost. Bd. 100. H. 1. 2008 S. 110-8
Calatzis, A; Peetz, D; Haas, S et al.
Prothrombinase-induced clotting time assay for determination of the anticoagulant effects of unfractionated and low-molecular-weight heparins, fondaparinux, and thrombin inhibitorsAm J Clin Pathol. Bd. 130. H. 3. 2008 S. 446-454
Schnabel, R; Lubos, E; Messow, CM et al.
Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study.Am Heart J. Bd. 156. H. 6. 2008 S. 1201.e1-11
Dorweiler, B; Torzewski, M; Dahm, M et al.
Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neo-intimaThromb Haemost. Bd. 99. 2008 S. 373-381
Hurst, J; von Landenberg, P
Toll-like receptors and autoimmunityAutoimmun Rev. Bd. 7. H. 3. 2008 S. 204-208
Lackner, KJ
Torcetrapib and coronary eventsN Engl J Med. Bd. 358. 2008 S. 1862-1863
Grus, FH; Joachim, SC; Sandmann, S et al.
Transthyretin and complex protein pattern aqueous humor of patients with primary open-angle glaucomaMol Vis. Bd. 14. 2008 S. 1437-1445
Dörr, S; Beran, A; Zimmermann, M et al.
Vergleich unterschiedlicher zeitpunkte des postoperativen Ernährungsbeginns auf Parameter der GranulozytenfunktionAnästhesiologie & Intensivmedizin Abstract. H. CD. 2008 S. PO3.7.5
Joachim, SC; Bruns, K; Lackner, KJ et al.
Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with "wet" age-related macular degeneration.Graefes Arch Clin Exp Ophthalmol. Bd. 245. H. 5. 2007 S. 619-26
Joachim, SC; Bruns, K; Lackner, KJ et al.
Antibodies to alpha B-crystallin, vimentin, and heat shock protein 70 in aqueous humor of patients with normal tension glaucoma and IgG antibody patterns against retinal antigen in aqueous humor.Curr Eye Res. Bd. 32. H. 6. 2007 S. 501-9
von Landenberg, P; Doring, Y; Modrow, S et al.
Are antiphospholipid antibodies an essential requirement for an effective immune response to infections?Ann N Y Acad Sci. Bd. 1108. 2007 S. 578-83
Metzger, J; von Landenberg, J; Kehrel, M et al.
Biosensor analysis of ß2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infectious-induced antibodies.Clin Chem. Bd. 53. 2007 S. 1137-1143
Lauterbach, M; Horstick, G; Plum, N et al.
C1-esterase inhibitor reverses functional consequences of superior mesenteric artery ischemia/reperfusion by limiting reperfusion injury and restoring microcirculatory perfusion.Shock. Bd. 27. H. 1. 2007 S. 75-83
Torzewski, M; Ochsenhirt, V; Kleschyov, AL et al.
Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.Arterioscler Thromb Vasc Biol. Bd. 27. H. 4. 2007 S. 850-7
Bertsch, T; Dikkeschei, B; Gurr, E et al.
Development and calibration of a new point-of-care test for the determination of NT-proBNP in whole blood.Clin Lab. Bd. 53. H. 7-8. 2007 S. 423-31
Espinola-Klein, C; Ruoorecht, HJ; Bickel, C et al.
Different calculations of ankle brachial index and cardiovascular risk predictionCirculation. Bd. 116. H. 16. 2007 S. 699
Rossmann, H; Büchler, E; Wenzel, JJ et al.
Evaluation of a new pooling strategy based on leukocyte count for rapid quantification of allele frequencies.Clin Chem. Bd. 53. 2007 S. 980-982
Espinola-Klein, C; Rupprecht, HJ; Bickel, C et al.
Glutathione peroxidase-1 activity, atherosclerotic burden, and cardiovascular prognosis.Am J Cardiol. Bd. 99. H. 6. 2007 S. 808-12
Wenzel, JJ; Rossmann, H; Lackner, KJ et al.
Human gene mutations. Gene symbol: MEN1. Disease: MEN1, multiple endocrine neoplasia, Type 1Hum Genet. Bd. 122. 2007 S. 210
von Landenberg, P; Lehmann, HW; Modrow, S
Human parvovirus B19 infection and antiphospholipid antibodies.Autoimmun Rev. Bd. 6. H. 5. 2007 S. 278-85
Fottner, C; Rossmann, H; Minnemann, T et al.
Identification of a novel germline mutation of the MEN I - gene (r.400delu) in a 24 year old patient with multifocal pancreatic insulinomas, primary hyperparathyroidism and a microprolactinomaExp Clin Endocr Diab. Bd. 115. 2007 S. sup 1
Espinola-Klein, C; Rupprecht, HJ; Bickel, C et al.
Impact of metabolic syndrome on atherosclerotic burden and cardiovascular prognosis.Am J Cardiol. Bd. 99. H. 12. 2007 S. 1623-8
Tsimikas, S; Aikawa, M; Miller, FJ et al.
Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering. A potential biomarker of early atherosclerosis regression.Arterioscler Thromb Vasc Biol. Bd. 27. 2007 S. 175-181
Espinola-Klein, C; Rupprecht, HJ; Bickel, C et al.
Inflammation, atherosclerotic burden and cardiovascular prognosis.Atherosclerosis. Bd. 195. H. 2. 2007 S. e126-34
Reifenberg, K; Lehr, HA; Torzewski, M et al.
Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice.Am J Pathol. Bd. 171. H. 2. 2007 S. 463-72
Lackner, KJ
Krankheiten durch Störungen des Fettstoffwechsels.Gerok, Huber, Meinertz, Zeidler (Hrsg). Die Innere Medizin. 11. Aufl. Stuttgart: Schattauer Verlag 2007
Lackner, KJ; Schmitz, G
Labordiagnostik der DyslipoproteinämienSchwandt P, Parhofer KG (Hrsg). Handbuch der Fettstoffwechselstörungen. 3. Aufl. Stuttgart: Schattauer Verlag 2007
Lehmann, WD; Kruger, R; Salek, M et al.
Neutral loss-based phosphopeptide recognition: a collection of caveats.J Proteome Res. Bd. 6. H. 7. 2007 S. 2866-73
Buhl, A; Metzger, JH; Heegaard, NH et al.
Novel Biosensor-Based Analytic Device for the Detection of Anti-Double-Stranded DNA Antibodies.Clin Chem. Bd. 53. 2007 S. 334-341
Wenzel, JJ; Rossmann, H; Lackner, KJ et al.
Novel human pathological mutations. Gene symbol: MEN1. Disease: MEN1, Multiple endocrine neoplasia, type 1.Hum Genet. Bd. 122. H. 3-4. 2007 S. 416
von Landenberg, P; Bauer, S
Nucleic acid recognizing Toll-like receptors and autoimmunity.Curr Opin Immunol. Bd. 19. H. 6. 2007 S. 606-10
Wenzel, P; Hink, U; Oelze, M et al.
Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2-/- mice.Br J Pharmacol. Bd. 150. H. 4. 2007 S. 526-33
Schlitt, A; Heine, GH; Jiang, XC et al.
Phospholipid Transfer Protein in Hemodialysis Patients.Am J Nephrol. Bd. 27. 2007 S. 138-143
Kruger, R; Wolschin, F; Weckwerth, W et al.
Plant protein phosphorylation monitored by capillary liquid chromatography--element mass spectrometry.Biochem Biophys Res Commun. Bd. 355. H. 1. 2007 S. 89-96
Sinning, JM; Bickel, C; Sinning, C et al.
Procalcitonin for risk stratification in stable coronary artery disease: Results from the atherogene studyCirculation. Bd. 116. H. 16. 2007 S. 851